IRIS Institutional Research Information System - OPENBS Open Archive UniBS

ROMANI, Chiara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.237
EU - Europa 2.309
AS - Asia 2.257
SA - Sud America 336
Continente sconosciuto - Info sul continente non disponibili 161
AF - Africa 51
OC - Oceania 9
AN - Antartide 1
Totale 10.361
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.115
SG - Singapore 773
CN - Cina 689
PL - Polonia 617
IT - Italia 481
BR - Brasile 276
DE - Germania 269
UA - Ucraina 250
HK - Hong Kong 237
VN - Vietnam 167
FI - Finlandia 159
GB - Regno Unito 117
FR - Francia 104
TR - Turchia 80
BD - Bangladesh 79
CA - Canada 74
IN - India 65
IE - Irlanda 64
RU - Federazione Russa 61
NL - Olanda 45
ID - Indonesia 33
MX - Messico 31
SE - Svezia 29
AR - Argentina 28
ZA - Sudafrica 24
EE - Estonia 23
IQ - Iraq 23
ES - Italia 20
JP - Giappone 20
AT - Austria 11
CZ - Repubblica Ceca 11
PK - Pakistan 11
BE - Belgio 10
LT - Lituania 9
AU - Australia 8
EC - Ecuador 8
KG - Kirghizistan 8
KR - Corea 7
BG - Bulgaria 6
CO - Colombia 6
NP - Nepal 6
TW - Taiwan 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
LK - Sri Lanka 5
MA - Marocco 5
SA - Arabia Saudita 5
AZ - Azerbaigian 4
EG - Egitto 4
IL - Israele 4
JO - Giordania 4
KZ - Kazakistan 4
MY - Malesia 4
NG - Nigeria 4
NI - Nicaragua 4
PH - Filippine 4
PY - Paraguay 4
UZ - Uzbekistan 4
VE - Venezuela 4
CR - Costa Rica 3
DZ - Algeria 3
EU - Europa 3
HN - Honduras 3
KE - Kenya 3
PT - Portogallo 3
AL - Albania 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
HU - Ungheria 2
LU - Lussemburgo 2
LV - Lettonia 2
OM - Oman 2
PE - Perù 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AM - Armenia 1
AQ - Antartide 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DK - Danimarca 1
ET - Etiopia 1
GD - Grenada 1
GR - Grecia 1
IR - Iran 1
JM - Giamaica 1
KH - Cambogia 1
LC - Santa Lucia 1
LY - Libia 1
ML - Mali 1
MT - Malta 1
MU - Mauritius 1
NO - Norvegia 1
Totale 10.200
Salva come PNG Salva come JPEG
Città #
Warsaw 612
Ashburn 542
Fairfield 466
Singapore 458
Woodbridge 328
San Jose 309
Houston 283
Chandler 241
Seattle 219
Hong Kong 215
New York 189
Jacksonville 175
Wilmington 165
Beijing 149
Cambridge 143
The Dalles 142
Los Angeles 132
Ann Arbor 128
Dearborn 106
Helsinki 104
Princeton 101
Brescia 96
Council Bluffs 79
Dublin 64
Nanjing 63
Istanbul 59
Munich 59
Dallas 58
Lauterbourg 55
Milan 53
Columbus 46
Shanghai 46
Dong Ket 44
Buffalo 41
Chicago 39
Ho Chi Minh City 39
São Paulo 37
London 33
Des Moines 31
Hanoi 31
San Francisco 31
Santa Clara 30
Moscow 29
Toronto 27
Orem 25
Denver 24
Jakarta 23
Tallinn 23
Montreal 21
San Diego 21
Redondo Beach 20
Shenyang 20
Tianjin 20
Jinan 19
Johannesburg 19
Phoenix 19
Turku 19
Chennai 18
Nanchang 18
Rome 17
Tokyo 17
Brooklyn 16
Kunming 15
Central 14
Changsha 14
Hangzhou 14
Nuremberg 14
Hebei 13
Mexico City 13
Poplar 13
Guangzhou 12
Jiaxing 12
Stockholm 12
Charlotte 11
Paris 11
Zhengzhou 11
Atlanta 10
Boston 10
Manchester 10
Monmouth Junction 10
Kyiv 9
Amsterdam 8
Ankara 8
Belo Horizonte 8
Bishkek 8
Lappeenranta 8
Miami 8
Mumbai 8
Norwalk 8
Verona 8
Brussels 7
Falkenstein 7
Frankfurt am Main 7
Haiphong 7
Leawood 7
Rio de Janeiro 7
Vancouver 7
Baghdad 6
Boardman 6
Curitiba 6
Totale 7.023
Salva come PNG Salva come JPEG
Nome #
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2916-21. doi: 10.1073/pnas.1222577110. Epub 2013 Jan 28. Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma. Zhao S1, Choi M, Overton JD, Bellone S, Roque DM, Cocco E, Guzzo F, English DP, Varughese J, Gasparrini S, Bortolomai I, Buza N, Hui P, Abu-Khalaf M, Ravaggi A, Bignotti E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Carrara L, Pecorelli S, Silasi DA, Ratner E, Azodi M, Schwartz PE, Rutherford TJ, Stiegler AL, Mane S, Boggon TJ, Schlessinger J, Lifton RP, Santin AD 365
Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues 364
Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients. 332
Claudin3 is localized outside the tight junctions in human carcinomas 298
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 288
Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin M in epithelial ovarian cancer diagnosis. 227
Correlation between serological immune response analyzed by a new ELISA for HPV-16/18 E7 oncoprotein and clinical characteristics of cervical cancer patients. 221
Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer 217
Class III β-tubulin overexpression in ovarian clear cell and serous carcinoma as a maker for poor overall survival after platinum/taxane chemotherapy and sensitivity to patupilone 212
Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy. 207
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma 205
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis. 204
FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients 202
Gene expression profiling to improve prognostic characterization of olfactory neuroblastoma and to define new targetable pathways 196
Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma 194
Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. 193
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma 190
Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial 188
Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissues. 187
Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma 183
Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions 181
Development and characterization of a human single-chain antibody fragment against claudin-3: a novel therapeutic target in ovarian and uterine carcinomas. 177
Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management. 177
Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence 177
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition 175
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis 174
Trefoil factor 3: a novel serum marker identified by gene expression profiling in highgrade endometrial carcinomas 172
HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities. 167
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome 153
The HIV-protease inhibitor saquinavir reduces proliferation, invasion and clonogenicity in cervical cancer cell lines 150
Claudin 7 downregulation is predictive of distant metastasis in high-grade serous carcinoma patients 147
Gene expression profiling of olfactory neuroblastoma helps identify prognostic pathways and define potentially therapeutic targets 146
Polymerase ε (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro 145
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 145
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer 144
Clinical and Histological Prognostic Factors of Recurrence and Malignant Transformation in a Large Series of Oral Potentially Malignant Disorders 139
Functional profiles of curatively treated adenoid cystic carcinoma unveil prognostic features and potentially targetable pathways 139
The claudin-low subtype of high-grade serous ovarian carcinoma exhibits stem cell features 138
Prenatal presentation and postnatal evolution of a patient with Jansen metaphyseal dysplasia with a novel missense mutation in PTH1R. 136
Stability of circulating miRNA in saliva: The influence of sample associated pre-analytical variables 135
Uso di miRNA come biomarcatori per la diagnosi e prognosi del carcinoma orale a cellule squamose 131
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients 120
Integrated mutational landscape analysis of uterine leiomyosarcomas 119
Human kallikrein 5: an interesting novel biomarker in ovarian cancer patients that elicits humoral response. 118
New Challenges in Evaluating Outcomes after Immunotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma 116
OVEREXPRESSION OF EPIDERMAL GROWTH FACTOR TYPE-1 RECEPTOR (EGF-R1) IN CERVICAL CANCER: IMPLICATIONS FOR CETUXIMAB-MEDIATED THERAPY IN RECURRENT/METASTATIC DISEASE. 116
Integrated Biomarker Analysis Reveals L1CAM as a Potential Stratification Marker for No Specific Molecular Profile High-Risk Endometrial Carcinoma 115
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients 113
L1CAM expression as a predictor of platinum response in high-risk endometrial carcinoma 111
HE4 and epithelial ovarian cancer : Comparison and clinical evaluation of two immunoassays and a combination algorithm 107
The expression level of VEGFR2 regulates mechanotransduction, tumor growth and metastasis of high grade serous ovarian cancer cells 106
Human papillomavirus type 16 (HPV-16) virus-like particleL1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines. 104
Trop-2 Overexpression in Poorly Differentiated Endometrial Endometrioid Carcinoma: Implications for Immunotherapy With hRS7, a Humanized Anti-Trop-2 Monoclonal Antibody 98
The VEGF/VEGFR2 system in ovarian cancer: From functional to pharmacological significance 96
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 96
Comprehensive Profiling of Hypoxia-Related miRNAs Identifies miR-23a-3p Overexpression as a Marker of Platinum Resistance and Poor Prognosis in High-Grade Serous Ovarian Cancer 92
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy 90
Correction for Li et al., Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 90
The prognostic role of salivary miRNAs in oral squamous cell carcinoma: technical challenges and clinical perspectives 88
Revisiting the concept of neoadjuvant and induction therapy in head and neck cancer with the advent of immunotherapy 85
Finding the junction between claudins and endometrial carcinoma 82
The interplay of hypoxia, inflammation, and microbiota as indicators of malignant transformation in oral potentially malignant disorders 74
Identification of optimal reference RNAs to normalize miRNA expression data by qRT-PCR in formalin-fixed, paraffin-embedded lymph node tissue 73
Bacterial cytoplasm as an effective cell compartment for producing functional VHH-based affinity reagents and Camelidae IgG-like recombinant antibodies 70
VEGF-D Serum Level as a Potential Predictor of Lymph Node Metastasis and Prognosis in Vulvar Squamous Cell Carcinoma Patients 51
Mammaglobin B (SCGB2A1) is a novel tumor antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy 43
HPV16VLP L1-Specific CD8+ cytotoxic T lymphocytes (CTL) are equally effective as E7-specific CD8+ CTL in killing autologous HPV16 positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines 41
Aberrant VEGFR2 supports tumor growth by extracellular matrix remodeling 26
Totale 10.361
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.899
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.899
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022480 0 92 11 3 5 32 48 28 26 97 38 100
2022/2023611 90 38 32 40 60 126 8 66 84 6 35 26
2023/2024775 38 25 78 56 43 189 45 45 124 44 15 73
2024/20251.425 28 41 29 246 112 148 109 51 137 94 265 165
2025/20263.336 310 273 213 472 391 263 562 134 207 285 173 53
2026/2027239 162 77 0 0 0 0 0 0 0 0 0 0
Totale 10.361